Clinical Recognition and Management of Tularemia in Missouri: A Retrospective Records Review of 121 Cases
Author(s) -
Ingrid Weber,
George Turabelidze,
Sarah Patrick,
Kevin S. Griffith,
Kiersten J. Kugeler,
Paul S. Mead
Publication year - 2012
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cis706
Subject(s) - tularemia , medicine , ciprofloxacin , epidemiology , retrospective cohort study , francisella tularensis , medical record , antibiotics , surgery , intensive care medicine , pediatrics , pathology , virulence , microbiology and biotechnology , biochemistry , chemistry , gene , biology
Clinical recognition of tularemia is essential for prompt initiation of appropriate antibiotic treatment. Although fluoroquinolones have desirable attributes as a treatment option, limited data on efficacy in the US setting exist.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom